6-12120275-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002114.4(HIVEP1):c.480T>A(p.Asp160Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HIVEP1 | ENST00000379388.7 | c.480T>A | p.Asp160Glu | missense_variant | 4/9 | 1 | NM_002114.4 | ENSP00000368698.2 | ||
HIVEP1 | ENST00000541134.5 | c.480T>A | p.Asp160Glu | missense_variant | 4/9 | 5 | ||||
HIVEP1 | ENST00000627968 | c.-5824T>A | 5_prime_UTR_variant | 4/8 | 5 | ENSP00000486543.2 | ||||
HIVEP1 | ENST00000442081.6 | c.166+341T>A | intron_variant | 3 | ENSP00000409078.3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249368Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135304
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461846Hom.: 0 Cov.: 39 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.480T>A (p.D160E) alteration is located in exon 4 (coding exon 3) of the HIVEP1 gene. This alteration results from a T to A substitution at nucleotide position 480, causing the aspartic acid (D) at amino acid position 160 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at